Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease.

Bernstein DE, Tran A, Martin P, Kowdley KV, Bourliere M, Sulkowski MS, Pockros PJ, Renjifo B, Wang D, Shuster DL, Cohen DE, Jacobson IM.

Kidney Int Rep. 2018 Oct 16;4(2):245-256. doi: 10.1016/j.ekir.2018.10.005. eCollection 2019 Feb.

2.

Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection.

Amin J, Boyd MA, Kumarasamy N, Moore CL, Losso MH, Nwizu CA, Mohapi L, Kerr SJ, Sohn AH, Teppler H, Renjifo B, Molina JM, Emery S, Cooper DA; SECOND-LINE.

PLoS One. 2015 Oct 9;10(10):e0140623. doi: 10.1371/journal.pone.0140623. eCollection 2015. No abstract available.

3.

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

Boyd MA, Moore CL, Molina JM, Wood R, Madero JS, Wolff M, Ruxrungtham K, Losso M, Renjifo B, Teppler H, Kelleher AD, Amin J, Emery S, Cooper DA; SECOND-LINE study group.

Lancet HIV. 2015 Feb;2(2):e42-51. doi: 10.1016/S2352-3018(14)00061-7. Epub 2015 Jan 20.

PMID:
26424460
4.

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection.

Amin J, Boyd MA, Kumarasamy N, Moore CL, Losso MH, Nwizu CA, Mohapi L, Kerr SJ, Sohn AH, Teppler H, Renjifo B, Molina JM, Emery S, Cooper DA.

PLoS One. 2015 Feb 27;10(2):e0118228. doi: 10.1371/journal.pone.0118228. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0140623.

5.

Recommendations for evaluation and management of bone disease in HIV.

Brown TT, Hoy J, Borderi M, Guaraldi G, Renjifo B, Vescini F, Yin MT, Powderly WG.

Clin Infect Dis. 2015 Apr 15;60(8):1242-51. doi: 10.1093/cid/civ010. Epub 2015 Jan 21.

6.

Pharmacokinetic enhancement in HIV antiretroviral therapy: a comparison of ritonavir and cobicistat.

Renjifo B, van Wyk J, Salem AH, Bow D, Ng J, Norton M.

AIDS Rev. 2015 Jan-Mar;17(1):37-46. Review.

PMID:
25586481
7.

Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes.

Koulinska IN, Villamor E, Msamanga G, Fawzi W, Blackard J, Renjifo B, Essex M.

Virus Res. 2006 Sep;120(1-2):191-8. Epub 2006 Apr 18.

PMID:
16621098
8.

Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.

Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, Fawzi W, Hunter D.

Clin Infect Dis. 2006 Mar 15;42(6):843-52. Epub 2006 Feb 9. Erratum in: Clin Infect Dis. 2006 Sep 1;43(5):671.

PMID:
16477563
9.

Transmission of cell-free and cell-associated HIV-1 through breast-feeding.

Koulinska IN, Villamor E, Chaplin B, Msamanga G, Fawzi W, Renjifo B, Essex M.

J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):93-9. Erratum in: J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):650.

PMID:
16340480
10.

Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D.

Renjifo B, Gilbert P, Chaplin B, Msamanga G, Mwakagile D, Fawzi W, Essex M; Tanzanian Vitamin and HIV Study Group.

AIDS. 2004 Aug 20;18(12):1629-36.

PMID:
15280773
11.

Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection.

Koulinska IN, Chaplin B, Mwakagile D, Essex M, Renjifo B.

AIDS Res Hum Retroviruses. 2003 Dec;19(12):1115-23.

PMID:
14709248
12.

In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.

Renjifo B, Chung M, Gilbert P, Mwakagile D, Msamanga G, Fawzi W, Essex M.

Virology. 2003 Mar 15;307(2):278-82.

13.

Herpes simplex virus type 2 infection among bar and hotel workers in northern Tanzania: prevalence and risk factors.

Kapiga SH, Sam NE, Shao JF, Masenga EJ, Renjifo B, Kiwelu IE, Manongi R, Fawzi WW, Essex M.

Sex Transm Dis. 2003 Mar;30(3):187-92.

PMID:
12616132
14.

HIV type 1 subtypes among bar and hotel workers in Moshi, Tanzania.

Kiwelu IE, Renjifo B, Chaplin B, Sam N, Nkya WM, Shao J, Kapiga S, Essex M.

AIDS Res Hum Retroviruses. 2003 Jan 1;19(1):57-64.

PMID:
12596722
15.

Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania.

Fawzi W, Msamanga G, Spiegelman D, Renjifo B, Bang H, Kapiga S, Coley J, Hertzmark E, Essex M, Hunter D.

J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):331-8.

PMID:
12439210
16.

Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality.

Fawzi WW, Msamanga GI, Hunter D, Renjifo B, Antelman G, Bang H, Manji K, Kapiga S, Mwakagile D, Essex M, Spiegelman D.

AIDS. 2002 Sep 27;16(14):1935-44.

PMID:
12351954
17.

Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania.

Koulinska IN, Msamanga G, Mwakagile D, Essex M, Renjifo B.

AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):947-56.

PMID:
12230937
18.

HIV-1 epidemic among female bar and hotel workers in northern Tanzania: risk factors and opportunities for prevention.

Kapiga SH, Sam NE, Shao JF, Renjifo B, Masenga EJ, Kiwelu IE, Manongi R, Fawzi W, Essex M.

J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):409-17.

PMID:
11917247
19.

Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.

Ndung'u T, Lu Y, Renjifo B, Touzjian N, Kushner N, Pena-Cruz V, Novitsky VA, Lee TH, Essex M.

J Virol. 2001 Dec;75(23):11417-25.

20.

HIV-1 LTR subtype and perinatal transmission.

Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D, Hunter D, Spiegelman D, Sharghi N, Kagoma C, Essex M.

Virology. 2001 Sep 1;287(2):261-5.

21.

Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women.

Fawzi W, Msamanga G, Renjifo B, Spiegelman D, Urassa E, Hashemi L, Antelman G, Essex M, Hunter D.

AIDS. 2001 Jun 15;15(9):1157-65.

PMID:
11416718
22.
23.

A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania.

Koulinska IN, Ndung'u T, Mwakagile D, Msamanga G, Kagoma C, Fawzi W, Essex M, Renjifo B.

AIDS Res Hum Retroviruses. 2001 Mar 20;17(5):423-31.

PMID:
11282011
24.

Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes.

Renjifo B, Fawzi W, Mwakagile D, Hunter D, Msamanga G, Spiegelman D, Garland M, Kagoma C, Kim A, Chaplin B, Hertzmark E, Essex M.

J Hum Virol. 2001 Jan-Feb;4(1):16-25.

PMID:
11213929
25.

Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana.

Ndung'u T, Renjifo B, Novitsky VA, McLane MF, Gaolekwe S, Essex M.

Virology. 2000 Dec 20;278(2):390-9.

26.

A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS.

Brites C, Gilbert MJ, Pedral-Sampaio D, Bahia F, Pedroso C, Alcantara AP, Sasaki MD, Matos J, Renjifo B, Essex M, Whitmore JB, Agosti JM, Badaro R.

J Infect Dis. 2000 Nov;182(5):1531-5. Epub 2000 Oct 9.

PMID:
11023477
27.

Diversity of the HIV-1 long terminal repeat following mother-to-child transmission.

Blackard JT, Renjifo B, Chaplin B, Msamanga G, Fawzi W, Essex M.

Virology. 2000 Sep 1;274(2):402-11.

28.

Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania.

Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D, Hertzmark E, Coley J, Garland M, Kapiga S, Antelman G, Essex M, Spiegelman D.

J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):246-54.

PMID:
10839660
29.

Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region.

Renjifo B, Gilbert P, Chaplin B, Vannberg F, Mwakagile D, Msamanga G, Hunter D, Fawzi W, Essex M.

AIDS. 1999 Sep 10;13(13):1613-21.

PMID:
10509561
30.

HIV-1 subtype B in Honduras.

Renjifo B, Blackard JT, Klaskala W, Chaplin BR, Shah P, McLane MF, Barin F, Esparza J, Zelaya JE, Osmanov S, Soto R, Fernandez JA, Baum MK, Essex ME.

Virus Res. 1999 Apr;60(2):191-7. No abstract available.

PMID:
10392727
31.

Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana.

Novitsky VA, Montano MA, McLane MF, Renjifo B, Vannberg F, Foley BT, Ndung'u TP, Rahman M, Makhema MJ, Marlink R, Essex M.

J Virol. 1999 May;73(5):4427-32.

32.

Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences.

Blackard JT, Renjifo BR, Mwakagile D, Montano MA, Fawzi WW, Essex M.

Virology. 1999 Feb 15;254(2):220-5.

33.

Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania.

Renjifo B, Chaplin B, Mwakagile D, Shah P, Vannberg F, Msamanga G, Hunter D, Fawzi W, Essex M.

AIDS Res Hum Retroviruses. 1998 May 1;14(7):635-8. No abstract available.

PMID:
9591718
34.

HIV-1 pol sequences from India fit distinct subtype pattern.

Soto-Ramirez LE, Tripathy S, Renjifo B, Essex M.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 1;13(4):299-307.

PMID:
8948366
35.

Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India.

Tripathy S, Renjifo B, Wang WK, McLane MF, Bollinger R, Rodrigues J, Osterman J, Tripathy S, Essex M.

AIDS Res Hum Retroviruses. 1996 Aug 10;12(12):1199-202. No abstract available.

PMID:
8844026
36.

Neurologic consequences of HTLV-II infection in injection-drug users.

Dooneief G, Marlink R, Bell K, Marder K, Renjifo B, Stern Y, Mayeux R.

Neurology. 1996 Jun;46(6):1556-60.

PMID:
8649548
37.

HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV.

Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Peña Cruz V, Chui DS, Osathanondh R, Mayer K, Lee TH, Essex M.

Science. 1996 Mar 1;271(5253):1291-3.

PMID:
8638113
38.

Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.

Renjifo B, Chou K, Soto Ramirez L, Garcia Vallejo F, Essex M.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S146-53. Review.

PMID:
8797717
39.

Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop.

Sankalé JL, de la Tour RS, Renjifo B, Siby T, Mboup S, Marlink RG, Essex ME, Kanki PJ.

AIDS Res Hum Retroviruses. 1995 May;11(5):617-23.

PMID:
7576918
40.

Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy.

Renjifo B, Borrero I, Essex M.

J Virol. 1995 Apr;69(4):2611-6. Erratum in: J Virol 1995 Jun;69(6):3964.

41.
42.
44.

cis-acting elements in the U3 region of a simian immunodeficiency virus.

Renjifo B, Speck NA, Winandy S, Hopkins N, Li Y.

J Virol. 1990 Jun;64(6):3130-4.

45.

Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.

Speck NA, Renjifo B, Golemis E, Fredrickson TN, Hartley JW, Hopkins N.

Genes Dev. 1990 Feb;4(2):233-42.

Supplemental Content

Loading ...
Support Center